Medical School Applicant Characteristics Associated With Performance in Multiple Mini-Interviews Versus Traditional

Mark C Henderson1, Carolyn J Kelly, Erin Griffin

  • 1M.C. Henderson is professor, Department of Internal Medicine, and associate dean for admissions, University of California, Davis, School of Medicine, Sacramento, California. C.J. Kelly is professor, Department of Medicine, and associate dean for admissions and student affairs, University of California, San Diego, School of Medicine, San Diego, California. E.J. Griffin is lead medical education evaluator, Office of Medical Education, University of California, Davis, School of Medicine, Sacramento, California. T.R. Hall is professor, Department of Radiology, and associate dean for admissions, David Geffen School of Medicine at UCLA, Los Angeles, California. A. Jerant is professor, Department of Family and Community Medicine, University of California, Davis, School of Medicine, Sacramento, California. E.M. Peterson is professor, Department of Pathology, and associate dean for admissions, University of California, Irvine, School of Medicine, Irvine, California. J.A. Rainwater is director of evaluation, Schools of Health and Clinical and Translational Science Center, University of California, Davis, School of Medicine, Sacramento, California. F.J. Sousa is assistant dean for admissions, University of California, Davis, School of Medicine, Sacramento, California. D. Wofsy is professor, Department of Medicine, and associate dean for admissions, University of California, San Francisco, School of Medicine, San Francisco, California. P. Franks is professor, Department of Family and Community Medicine, University of California, Davis, School of Medicine, Sacramento, California.

Summary

Disadvantaged (DA) applicants performed better in traditional interviews (TI) but worse in multiple mini-interviews (MMI). These findings on applicant characteristics impacting interview performance have workforce implications.

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
256
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.5K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
242